S
PFE icon

Sunpointe’s Pfizer PFE Stock Holding History

Sunpointe’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.51M Sell
53,819
-12,739
-19% -$339K 0.5% 45
2025
Q4 		$1.66M Buy
66,558
+2,513
+4% +$63.4K 0.55% 41
2025
Q3 		$1.63M Buy
64,045
+9,881
+18% +$244K 0.59% 40
2025
Q2 		$1.31M Buy
54,164
+44,916
+486% +$1.05M 0.52% 46
2025
Q1 		$234K Buy
9,248
+1,001
+12% +$26.2K 0.12% 155
2024
Q4 		$219K Buy
8,247
+215
+3% +$5.83K 0.11% 168
2024
Q3 		$232K Sell
8,032
-138
-2% -$4.03K 0.19% 140
2024
Q2 		$229K Sell
8,170
-2,566
-24% -$70.6K 0.15% 130
2024
Q1 		$298K Sell
10,736
-2,358
-18% -$65.4K 0.33% 93
2023
Q4 		$377K Buy
+13,094
New +$396K 0.48% 63

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Sunpointe's PFE Position: Q1 2026 in Review

Sunpointe reduced its Pfizer (PFE) stake by 19% in Q1 2026, selling an estimated $339K and leaving 53,819 shares worth $1.51M. The position accounts for 0.5% of the portfolio, ranked #45.

Sunpointe first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.66M in Q4 2025. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Sunpointe held 53,819 shares of Pfizer worth $1.51M as of Q1 2026.
  • Sunpointe sold 12,739 Pfizer shares in Q1 2026, an estimated $339K.
  • Pfizer made up 0.5% of Sunpointe's portfolio in Q1 2026, its #45 holding.
  • Sunpointe first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • Sunpointe's Pfizer position peaked at $1.66M in Q4 2025.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Sunpointe's 13F filing for Q1 2026, filed 21 Apr 2026.